Research, Reports, and Announcements
The U.S. Food and Drug Administration, to assist in its mission to protect and promote the public health, uses 49 committees and panels to obtain independent expert advice on scientific, technical, and policy matters. The public and Congress regularly show interest in these advisory committees (ACs), especially the screening for conflicts of interest and the use of waivers for some conflicts. Although the agency has taken a variety of steps to increase transparency and predictability of its ACs, FDA continues to seek opportunities to assess its advisory committee program for future improvement efforts.
Important messages to the public on events surrounding FDA advisory committees
Research and Reports
Special research studies and reports on FDA advisroy committee operations
FDA-TRACK Advisory Committees Financial Conflict-Of-Interest Disclosure And Voting Patterns At FDA Advisory Committee Meetings(PDF - 273KB) Measuring Conflict Of Interest and Expertise On FDA Advisory Committees(PDF - 456KB) Fiscal Year 2008 Annual Report on FDA Advisory Committee Vacancies and Public Disclosures(PDF - 697KB) Fiscal Year 2009 Annual Report on FDA Advisory Committee Vacancies and Public Disclosures(PDF - 1.1MB) Fiscal Year 2010 Annual Report on FDA Advisory Committee Vacancies and Public Disclosures(PDF - 3.2MB)